A milestone in modern holistic medicine

INUSPHERESIS®

In the age of massively increasing toxic loads, relief is the basic of every therapy. INUSpheresis® is one of the strongest options for causal research and cause-related therapy.

The proven method of the apheresis blood purification process has been scientifically developed by INUS since 2002 to INUSpheresis® as environmental apheresis® to eliminate toxins and chronic inflammation from the body quickly and with almost no side effects.

With INUSpheresis®, we wash out environmental toxins which cause illness and inflammation in the blood. We also reduce inflammation mediators such as CRP or TNF-a with INUSpheresis®. We filter out malformed autoimmune antibodies. We are therefore not countering the phenomenon of autoimmune diseases, which is growing rapidly worldwide, by counteracting “anti” agents, but by deliberately removing their triggering factors and their pathogenic reactants.

Welcome Note From Founder

Dr. Ioanna Gaka, Medical Director of INUSpheresis Athens

‘’We take care of your overall health, not just your current condition’’

Human beings are a psycho- emotional- mental- physical wholeness. Most of the times, the healing process requires to dive deep into the unseen parts of ourselves. A doctor-healer should have the ability and intention to understand what is hidden behind to what is manifested already in the body, the root cause.

This is what we call holistic approach, according to which we record, prioritize, and restore what caused us to lose our health and power to live fully. The basis of every treatment we offer, is the detoxification of the body, spirit and emotion and their reconstruction. There is tremendous power within us. We are here to reclaim it and express it. To find who we really are on all levels.

Apheresis as an effective, clinically proven treatment and disease-prevention therapy

How INUSPHERESIS® works

Apheresis as an effective, clinically proven treatment and disease-prevention therapy

INUSpheresis® is a blood plasma purification to remove disease-causing substances and environmental toxins. By relieving the human body, INUSpheresis® helps to strengthen the immune system and the body’s own self-healing powers.
The use of the most modern intelligent filter systems guarantees a gentle detoxification that is individually tailored to the patient and at the same time “effective”. The method used has the advantage of eliminating not only toxins absorbed from outside, but also allergens, metabolic waste products, inflammatory messengers, infection toxins and harmful proteins. Only pathogenic components are filtered from the plasma, while other healthy components are returned to the body.
The treatment is gentle and has few side effects and can be performed on an outpatient basis (takes about 2-3 hours). After the first INUSpheresis® session, these pathogenic agents are significantly decreased and can be removed completely by repetition.

The INUSpheresis® process

1. Analysis

INUSpheresis® filters out pathogenic structures in the blood which are then subjected to chemical and biochemical analyses to measure excreted toxin levels and plasma residues. These analysis results serve to monitor the treatment process.

2. Restoring Blood

Blood is collected and returned via arm veins with special cannulas. The disease-causing substances are filtered out and eliminated while the purified plasma returns to the body with all its good components.

3. Indications

The benefits of INUSpheresis® are best evident in autoimmune, inflammatory rheumatoid arthritis, polyneuropathy, and chronic fatigue syndrome. In such cases, the circulating immune complexes are greatly decreased.

Indications for INUSpheresis®

INUSpheresis® has a wide range of applications. It is suitable for people as a preventive measure, but also as an acute measure. Thus, this treatment can be used for the following clinical pictures and areas, among others:
  • Age-related macular degeneration – dry course
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Ulcerative colitis – failure of chemotherapy and/or threat of surgical removal of the bowel
  • Diabetic foot syndrome with threatened amputation of limbs in the event of failure of conservative and conventional surgical therapy
  • Dilated cardiomyopathy – beta-receptor antibody positive detection
  • Eaton-Lambert syndrome (tumor-associated nerve disorder)
  • Encephalitis disseminata (multiple sclerosis) – failure of interleukin-alpha therapy or antibody formation against therapeutic interleukin with progressive course
  • Familial heterocygous hypercholesterolemia with failure/NW of conservative therapy and/or premature and progressive atherosclerosis/heart attack/stroke/attack on renal vessels
  • Familial homocygous hypercholesterolemia
  • Focal sclerosing glomerulonephritis of the autologous kidneys or after kidney transplantation with nephrotic syndrome and/or severe hypertriglyceridemia with failure of chemotherapy/cholesterol synthesis inhibitor therapy and rapid increase in renal insufficiency (loss of kidney function)
  • Glomerulonephritis (inflammatory kidney disease) pathogenetically directed – failure and/or severe side effects of chemotherapy
  • Guillain Barre Syndrome – chronic/acute form
  • Haemophilia (hemophilia) with detection of antibodies against factor V
  • Inhibitor haemophilia (tendency to bleed) with factor V antibody detection
  • HLA sensitization in kidney transplantation
  • IgM associated polyneuropathy (tumour-associated nerve disorder)
  • Isolated familial Lp(a) hyperlipoproteinemia with premature atherosclerosis/heart attack/stroke/attack of renal vessels/operable arterial occlusive leg disease
  • Cryoglobulinemic vasculitis (autoimmune vasculitis caused by cold proteins)
  • Linear IgA dermatosis
  • Lupus erythematosus in failure/severe side effects of chemotherapy
  • Lupus erythematosus with progressive renal involvement (glomerulonephritis)
  • macular degeneration (adult form = adult) – dry form
  • Behcet’s disease – failure and/or severe side effects of chemotherapy
  • Raynaud’s disease – failure of conservative therapy
  • Refsum disease (memory disease)
  • Multiple sclerosis (see also Encephalitis disseminata)
  • Necrobiotic xanthogranulomatosis (with paraprotein)
  • Nephrotic syndrome in inflammatory kidney disease (glomerulonephritis)
  • pathogenetically guided – failure and/or severe side effects of chemotherapy
  • Pemphigus foliaceus failure and/or severe side effects of chemotherapy
  • Pemphigus vulgaris failure and/or severe side effects of chemotherapy
  • Peripheral arterial occlusive disease (pathogenetically directed) in the event of failure of conservative and conventional surgical therapy options and threatened loss of limbs
  • Polymyositis – failure and/or severe side effects of chemotherapy
  • Retinopathy pigmentosa in Refsum disease
  • Rheumatoid arthritis – in failure of chemotherapy and extreme progression
  • Scleroderma progressive systemic with renal involvement (glomerulonephritis)
  • Scleromyxedema Arndt-Gottron – with kidney infestation and detection of paraprotein – failure and/or severe side effects of chemotherapy
  • Stiff-Man syndrome
  • Thrombangiitis obliterans (alternative to amputation)
  • Transplant vasculopathy after heart transplant
  • Xanthogranulomatosis (necrobiotic) with paraprotein

Frequently asked Questions

What exactly is eliminated from the body?
How INUSpheresis® is performed?
What are the benefits of INUSpheresis®?
What substances usually eliminated during INUSpheresis®?
How will my blood be replaced?
How can I expect to feel after apheresis?
How does INUSpherese® directly impact physical health?
How can rheumatic patients benefit from INUSpheresis®?
How can INUSpheresis® be used in chronic fatigue syndrome?
Can INUSpheresis® benefit patients with coronary heart diseases?
Can INUSpheresis® help if I have hepatitis C?
Is INUSpheresis® some sort of dialysis?
How Does INUSpherese® Differ from other procedures?
Does INUSpherese® Differ from plasma exchange?
Are INUSpheresis® and therapeutic apheresis the same?
How I know if I can have INUSpheresis®?
Our Clients

Testimonials

Lets Talk

Contact Us